Umbilical Cord Blood Stem Cells
PremierMaxCB®: Revolutionizing Regenerative Medicine
Look no further than PremierMaxCB®, the most scientifically advanced umbilical cord blood-derived stem cell product available today.
Developed by Cord for Life® and distributed through RejuvionBio, PremierMaxCB® harnesses the regenerative potential of hematopoietic stem cells (HSCs) and key growth factors. Backed by rigorous science and an ongoing FDA-approved Phase 1 trial, this is the tool physicians need to elevate their practice and research.
Why PremierMaxCB® Stands Above the Rest
Superior Stem Cell Recovery
Our proprietary PremierMax® processing system recovers 35% more stem cells than competitors, ensuring maximum potency for your patients.
Purity That Matters
Removes 98.5% of red blood cells without lysing, minimizing debris and enhancing safety—far surpassing the 70% average of other methods.
Proven Clinical Impact
Over 2,200 units released for transplants, research, and trials, with faster engraftment times (median 16 days vs. 20 days for competitors).
Tailored Dosing Options
Available in Silver (8M cells), Gold (15M cells), and Platinum (30M cells) 1mL vials—perfect for localized treatments like joint injections and soft tissue repair.
Remarkable Potential
Imagine offering a minimally manipulated, FDA-regulated biologic that’s already demonstrating remarkable potential in early research for conditions like sacroiliac joint (SIJ) syndrome, osteoarthritis, and tendon injuries.
Groundbreaking Science, FDA-Approved Innovation
PremierMaxCB® isn’t just another stem cell product—it’s a pioneer in regenerative medicine. RejuvionBio’s CEO, Dr. Mike Tillman played a critical role in this journey, contributing the foundational safety and efficacy data that secured FDA approval for an Investigational New Drug (IND) application. This milestone paved the way for a Phase 1 clinical trial at the University of Florida, currently recruiting patients to evaluate PremierMaxCB®-Platinum (CFL001) for symptomatic sacroiliac joint syndrome—a debilitating condition affecting millions.
Trial Status
As of July 31, 2024, this open-label, dose-ranging study is actively enrolling 9 patients to assess safety, tolerability, and preliminary efficacy.
Why It Matters
The data from this trial could redefine how physicians treat joint-related pain and soft tissue injuries, positioning PremierMaxCB® as a game-changer in orthopedics and regenerative therapy.
With decades of cord blood expertise and adherence to cGMP standards, PremierMaxCB® is manufactured in state-of-the-art ISO 7 and ISO 6 clean rooms, ensuring sterility, potency, and compliance with the highest regulatory standards (FDA, NMDP, AABB).
The Science Behind the Solution
Umbilical cord blood is a rich source of hematopoietic stem cells (HSCs), immune cells, and bioactive proteins like VEGF (angiogenesis), IL-1ra (anti-inflammatory), and bFGF (tissue repair).
PremierMaxCB® delivers a cellular and protein cocktail designed to promote tissue regeneration, reduces inflammation, and accelerates recovery—without the risks of surgical stem cell harvesting or the limitations of autologous therapies.
Independent third-party studies confirm
Cell Viability
Over 60% viable cells, with counts exceeding 10 million per vial.
Key Markers
Presence of CD34+CD45+ (HSCs), CD73, and CD90 (MSCs), alongside immune-modulating proteins.
Therapeutic Potential
Faster neutrophil engraftment and superior clonogenic potential.
Implement PremierMaxCB® into Your Practice
1.
Become a PremierMaxCB® Provider Today
Ready to bring this cutting-edge therapy to your patients? Joining the RejuvionBio network is simple:
Register
Visit RejuvionBio.store to create your physician account.
Approval
Email info@RejuvionBio.com with your details for fast approval.
Order
Start placing research-use orders and receive blind copies for tracking.
As a PremierMaxCB® provider, you’ll gain access to a product trusted by leading surgeons and clinics, backed by RejuvionBio’s commitment to innovation and patient care. Our CEO’s leadership in securing FDA approval underscores our dedication to advancing regenerative medicine—partner with us to lead the charge.
2.
Elevate Your Practice with PremierMaxCB®
Contact us today or explore the science behind our product in the ongoing University of Florida trial (ClinicalTrials.gov ID). Together, we can redefine what’s possible in regenerative medicine.